Philips launches new range of patient monitors in Tanzania designed to provide access to high quality care at affordable costs
December 16, 2015
Dar es Salaam, Tanzania – Royal Philips (NYSE: PHG AEX: PHIA) has announced the launch of its Efficia CM Series patient monitors in Tanzania – these cost effective products are designed to provide clinicians with access to high-quality of care, even in resource-limited facilities. These solutions highlight Philips’ commitment to enhance access and enable quality care across the health continuum – from healthy living and prevention, to diagnosis, treatment, recovery and home care, including in remote areas. “As we innovate to improve health care, monetary constraints should not be a reason for limiting access to the best care available for improving a patient’s health,” said Roelof Assies, General Manager, Philips East Africa. “The Efficia suite is designed to bring trusted and effective Philips technology and performance at an affordable price to the health care facilities where resource limitations have prevented this access before.” Effective patient monitoring can help improve diagnosis and provide earlier intervention, which is not only critical for improving patient outcomes, but can also help hospitals improve operational efficiencies.
Making quality care affordable
The Efficia CM Series patient monitors provide the same core physiological measurements and algorithms that are present in other Philips patient monitors, but are designed to be more cost-effective and scalable to the needs of budget-constrained health care facilities.
The series, including Efficia CM100, Efficia CM120 and Efficia CM150, are solidly built and reliable, able to handle heavy workloads and electrostatic interference, and can be customized for a variety of patient types, acuity levels and clinical settings, and include an intuitive user-interface to ease the burden on busy clinician workflow. Efficia DFM100 - Providing therapeutic care where it is needed most
The Efficia CM patient monitors can be connected to Efficia CMS200 central monitoring system, which provides centralized monitoring and real-time access to patient physiological data and displays waveforms, parameters and alarms for up to 32 patients.
To deliver quality care, clinicians need to make quick, informed decisions when responding to an emergency and caring for a patient across the entire course of treatment. The Efficia DFM100 defibrillator/monitor is designed to be easy to use for both basic and advanced life support care providers to meet the demands of patient care in pre-hospital and hospital environments effectively and consistently. The Efficia DFM100 provides functionalities needed to enhance patient care, regardless of where they are located. It is also scalable to ensure affordability across all care settings.
“Clinicians are constantly under pressure to meet clinical demands on a tight budget,” said Dr. Juma A. Mfinanga, Head of Emergency Department at Muhimbili National Hospital. “The Efficia solutions work with the clinicians and the hospital; they are affordable and intuitive, allowing limited staff to focus on care first.”
For further information, please contact:
Radhika Choksey FleishmanHillard Tel: +27 11 548 2030
Philips Group Communications - Africa
Tel: +31 62525 9000
Email: radhika.choksey@philips.com
Natalie D’Amico
Email : Natalie.damico@fleishman.co.za
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2014 sales of EUR 21.4 billion and employs approximately 106,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www.philips.com/newscenter.
